Dana Sochorova (@sochorovadana) 's Twitter Profile
Dana Sochorova

@sochorovadana

Surgical trainee with HPB interest | @ALSGBandI Webinar Lead | @EAES_eu Young Members task force | @ESSOnews HPB group | @EurPancClub Education Committee

ID: 1104105346757476355

calendar_today08-03-2019 19:43:22

229 Tweet

449 Followers

975 Following

Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

🇪🇦 António Pinto da Costa presenting proof of concept study on #deepLearning in EUS and #pancreaticCyst: 🎞 real time assessesment 📍very promising, needs validation PD Dr. Felix Nickel EAES ESGE J. Enrique Dominguez-Munoz Enrique de-Madaria

🇪🇦 António Pinto da Costa presenting   
proof of concept study on #deepLearning in EUS and #pancreaticCyst:

🎞 real time assessesment
📍very promising, needs validation

<a href="/doctor_felix/">PD Dr. Felix Nickel</a> <a href="/EAES_eu/">EAES</a> <a href="/ESGE_news/">ESGE</a> <a href="/EDominguezMunoz/">J. Enrique Dominguez-Munoz</a> <a href="/DeMadaria/">Enrique de-Madaria</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Prof Marianne Pavel updates on pancreatic #NET and #PRRT: 🩸 consider toxicity (MDS, leukaemia) ☢️new ligands & isotopes available EPC-Europ Pancr Club 👥 ENETS collaboration at #EPC2024 👉 enets.org/guidelines.html ITM Isotope Technologies Munich SE NET CONNECT LACNETS Stefano Partelli Julie Hallet

Prof Marianne Pavel updates on pancreatic #NET and #PRRT:
🩸 consider toxicity (MDS, leukaemia)
☢️new ligands &amp; isotopes available

<a href="/EurPancClub/">EPC-Europ Pancr Club</a> 👥 <a href="/ENETS_ORG/">ENETS</a> collaboration at #EPC2024
👉 enets.org/guidelines.html
<a href="/ITM_Radiopharma/">ITM Isotope Technologies Munich SE</a> <a href="/net_connectinfo/">NET CONNECT</a> <a href="/LACNETS/">LACNETS</a>  <a href="/spartelli/">Stefano Partelli</a> <a href="/HalletJulie/">Julie Hallet</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

We all treat patients with #SpinalCord injury from time to time - but not often enough: 📊 interpret vital signs differently #autonomicDysreflexia 🩸normal labs even if unwell 🔊 listen to pts - they know a lot 👇 insights from Dr Georgie Budd 👇 Spinal Injuries Association RCEMLearning

Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Fantastic 1st day of #BOASTiC Surgical Trials Course - learning from the best Marion Campbell Jessie Elliott david beard: ☠️death sign in research question 🔥 be aware of "hot stuff" bias 📃is your trial pragmatic? precis-2.org Bristol Centre for Surgical Research SITU Oxford HRB-TMRN

Fantastic 1st day of  #BOASTiC Surgical Trials Course - learning from the best  <a href="/MarionKCampbell/">Marion Campbell</a> <a href="/JessieAElliott/">Jessie Elliott</a> <a href="/david_j_beard/">david beard</a>:

☠️death sign in research question
🔥 be aware of "hot stuff" bias
📃is your trial pragmatic? precis-2.org

<a href="/CSR_Bris/">Bristol Centre for Surgical Research</a> <a href="/SITU_Oxford/">SITU Oxford</a> <a href="/hrbtmrn/">HRB-TMRN</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

2⃣nd day #BOASTIC2024: ✈️feasibility study ≠ pilot study 📈Lasagna's law - always 🤯 🗨️ plan retention strategy early thanks to Kerry Avery Fiona Boland Marion Campbell for trial statistics made simple(r) tomorrow🐲Dragon´s #RCT den! Justin Wormald david beard HRB-TMRN

2⃣nd day #BOASTIC2024:

✈️feasibility study ≠ pilot study
📈Lasagna's law - always 🤯
🗨️ plan retention strategy early 

thanks to <a href="/KnlAvery/">Kerry Avery</a> <a href="/BolandFiona/">Fiona Boland</a> <a href="/MarionKCampbell/">Marion Campbell</a>  for trial statistics made simple(r)    

tomorrow🐲Dragon´s #RCT den!
 <a href="/JCRWormald/">Justin Wormald</a> <a href="/david_j_beard/">david beard</a> <a href="/hrbtmrn/">HRB-TMRN</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

NAT vs upfront surgery in resectable #PDAC: patient-level analysis of RCTs doi.org/10.1093/bjsope… 🚩different NAT regimes 🏴 pt selection bias 💊benefit of NAT only in cisplatin, epirubicin and gemcitabine arm Giovanni Marchegiani Julie Hallet Ville Sallinen Angela Lamarca

NAT vs upfront surgery in resectable #PDAC: patient-level analysis of RCTs doi.org/10.1093/bjsope…

🚩different NAT regimes 🏴 pt selection bias

💊benefit of NAT only in cisplatin, epirubicin and gemcitabine arm
 
<a href="/Gio_Marchegiani/">Giovanni Marchegiani</a> <a href="/HalletJulie/">Julie Hallet</a> <a href="/villesallinen/">Ville Sallinen</a> <a href="/DrAngelaLamarca/">Angela Lamarca</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

✈️ Coming to #ESSO43 in Antwerp? Don´t miss 📢 Pin your Project 📢 board at European Society of Surgical Oncology (ESSO) EYSAC booth 💡advertise your project & invite collaborators 📰 bring own flyer or 👇 use template below/fill one when you arrive! Gil Morgan, MD OncoAlert Stefan Stättner Andreas Brandl

✈️ Coming to #ESSO43 in Antwerp?  
Don´t miss 📢 Pin your Project 📢 board at <a href="/ESSOnews/">European Society of Surgical Oncology (ESSO)</a> <a href="/EYSAC1/">EYSAC</a>   booth 

 💡advertise your project  &amp; invite collaborators
📰 bring own flyer or 👇 use template below/fill one when you arrive!
<a href="/weoncologists/">Gil Morgan, MD</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/SStattner/">Stefan Stättner</a> <a href="/AndreasBrandl8/">Andreas Brandl</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Debate on prophylactic #HIPEC for T4 colorectal cancer at #ESSO43 - well-pointed arguments by Wim Ceelen 💥 Andreas Brandl: So far studies: unprecise T4 staging + MSI high pts + underpowered 👉 evidence is poor- need a (good) trial ⁉️ OncoAlert The Dukes' Club Arndt Vogel

Debate on prophylactic #HIPEC for T4 colorectal cancer at #ESSO43 -  well-pointed arguments by <a href="/WimCeelen/">Wim Ceelen</a> 💥 <a href="/AndreasBrandl8/">Andreas Brandl</a>: 

So far studies: unprecise T4 staging + MSI high pts + underpowered

👉  evidence is poor- need a (good)  trial ⁉️

<a href="/OncoAlert/">OncoAlert</a> <a href="/Dukes_Club/">The Dukes' Club</a>
<a href="/ArndtVogel/">Arndt Vogel</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Robotic hepatic resections at #ESSO43 by Stefan Stättner: use IWATE score to choose appropriate cases for your level 🫂 have a buddy to start the journey ✍️ the best time to develop training curriculum? 🤔 ➡️ now ! OncoAlert Julie Hallet Ville Sallinen Ernesto Sparrelid European Society of Surgical Oncology (ESSO)

Robotic hepatic resections at #ESSO43 by <a href="/SStattner/">Stefan Stättner</a>:

use IWATE score to choose appropriate cases for your level

🫂 have a buddy to start the journey

✍️ the best time to develop training curriculum? 🤔 ➡️ now !

<a href="/OncoAlert/">OncoAlert</a> <a href="/HalletJulie/">Julie Hallet</a>  <a href="/villesallinen/">Ville Sallinen</a> <a href="/sparrelid/">Ernesto Sparrelid</a> <a href="/ESSOnews/">European Society of Surgical Oncology (ESSO)</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Not only the council but also 📚EPC-Europ Pancr Club Education Committee worked hard today at #UEGWeek: 👨‍🎓new Academy website - coming soon 🎬don´t miss Nov 1⃣4⃣ webinar 👉t.ly/3gdSg Great to meet my committee-mates in person again Lucía Guilabert Anna Caterina Milanetto, MD Iris Levink

Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

M. Nothacker at 🇪🇺 #PDAC #QualityOfCare project kick-off meeting at #UEGWeek: ✍️guidelines ≠ implementation in practice 📊choose quality indicators wisely shorturl.at/LIWiC Joint EPC-Europ Pancr Club my_UEG venture - enthusiastic to contribute! AWMF Tomas Sebek

M. Nothacker at 🇪🇺 #PDAC #QualityOfCare  
project kick-off meeting at #UEGWeek: 

✍️guidelines ≠ implementation in practice
📊choose quality indicators wisely        shorturl.at/LIWiC

Joint <a href="/EurPancClub/">EPC-Europ Pancr Club</a> <a href="/my_ueg/">my_UEG</a> venture - enthusiastic to contribute! 
<a href="/AWMF_eV/">AWMF</a> <a href="/TamasSebek/">Tomas Sebek</a>
Dana Sochorova (@sochorovadana) 's Twitter Profile Photo

Insights from Brooke Wilson on #clinicalTrial pitfalls using PFS as primary outcome: rejecting 💊 (with large OS) due to small PFS approving those ↘️OS despite PFS gain European Society of Surgical Oncology (ESSO) -JMED webinar 📽️ at shorturl.at/KmbYq Common Sense Oncology Arndt Vogel Andreas Brandl OncoAlert

Insights from <a href="/drbrookewilson/">Brooke Wilson</a> on #clinicalTrial  pitfalls using PFS as primary outcome:   

rejecting 💊 (with large OS) due to small PFS approving those ↘️OS despite PFS gain

<a href="/ESSOnews/">European Society of Surgical Oncology (ESSO)</a> -JMED  webinar 📽️ at shorturl.at/KmbYq

<a href="/csoncol/">Common Sense Oncology</a> <a href="/ArndtVogel/">Arndt Vogel</a> <a href="/AndreasBrandl8/">Andreas Brandl</a>
<a href="/OncoAlert/">OncoAlert</a>